Table 2 ORs of poor CVH, CKD, retinopathy, NAFLD and advanced liver fibrosis among different T2D subgroups

Poor CVH (n = 3556)

 Model 1^a

0.23 (0.17, 0.31) < 0.001

1.21 (0.85, 1.74) 0.284

1.09 (0.54, 2.20) 0.798

 Model 2^b

0.11 (0.08, 0.17) < 0.001

1.28 (0.82, 2.00) 0.273

1.49 (0.68, 3.25) 0.317

 Model 3^c

0.08 (0.05, 0.12) < 0.001

0.74 (0.39, 1.40) 0.347

0.55 (0.23, 1.31) 0.178

CKD (n = 4051)

 Model 1^a

0.53 (0.37, 0.77) 0.001

0.86 (0.55, 1.35) 0.515

0.75 (0.33, 1.69) 0.479

 Model 2^b

0.55 (0.39, 0.79) 0.001

0.86 (0.55, 1.35) 0.514

0.72 (0.31, 1.67) 0.447

 Model 3^c

0.69 (0.48, 1.00) 0.049

0.61 (0.30, 1.24) 0.167

0.57 (0.25, 1.29) 0.176

Retinopathy (n = 2276)

 Model 1^a

1.05 (0.64, 1.74) 0.833

0.70 (0.40, 1.22) 0.203

3.57 (1.56, 8.15) 0.003

 Model 2^b

1.07 (0.64, 1.78) 0.799

0.67 (0.39, 1.16) 0.153

3.54 (1.57, 8.01) 0.003

 Model 3^c

1.18 (0.69, 2.01) 0.545

0.66 (0.32, 1.38) 0.263

2.94 (1.16, 7.48) 0.024

NAFLD (n = 2343)

 Model 1^a

0.57 (0.40, 0.82) 0.002

1.02 (0.69, 1.53) 0.905

1.17 (0.45, 3.02) 0.750

 Model 2^b

0.55 (0.38, 0.80) 0.002

1.01 (0.67, 1.53) 0.948

1.24 (0.48, 3.20) 0.658

 Model 3^c

0.64 (0.43, 0.95) 0.026

0.83 (0.49, 1.42) 0.492

1.33 (0.51, 3.49) 0.559

Advanced liver fibrosis (n = 4060)

 Model 1^a

0.19 (0.14, 0.27) < 0.001

0.48 (0.31, 0.74) 0.001

0.69 (0.24, 2.02) 0.500

 Model 2^b

0.20 (0.14, 0.27) < 0.001

0.47 (0.31, 0.73) 0.001

0.67 (0.23, 1.96) 0.465

 Model 3^c

0.21 (0.15, 0.29) < 0.001

0.68 (0.31, 1.50) 0.342

0.91 (0.29, 2.88) 0.868